nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—AR—hypertension	0.26	0.545	CbGaD
Nandrolone phenpropionate—CYP19A1—hypertension	0.217	0.456	CbGaD
Nandrolone phenpropionate—AR—Spironolactone—hypertension	0.124	1	CbGbCtD
Nandrolone phenpropionate—Progesterone—Eplerenone—hypertension	0.0606	0.186	CrCrCtD
Nandrolone phenpropionate—Testosterone Propionate—Eplerenone—hypertension	0.0606	0.186	CrCrCtD
Nandrolone phenpropionate—Progesterone—Spironolactone—hypertension	0.0527	0.162	CrCrCtD
Nandrolone phenpropionate—Testosterone Propionate—Spironolactone—hypertension	0.0527	0.162	CrCrCtD
Nandrolone phenpropionate—Testosterone—Eplerenone—hypertension	0.0526	0.162	CrCrCtD
Nandrolone phenpropionate—Testosterone—Spironolactone—hypertension	0.0458	0.141	CrCrCtD
Nandrolone phenpropionate—Norelgestromin—STS—hypertension	0.00188	0.412	CrCbGaD
Nandrolone phenpropionate—Gestodene—CYP3A5—hypertension	0.000258	0.0566	CrCbGaD
Nandrolone phenpropionate—Testosterone Propionate—CYP17A1—hypertension	0.000254	0.0557	CrCbGaD
Nandrolone phenpropionate—Nandrolone decanoate—AR—hypertension	0.000226	0.0495	CrCbGaD
Nandrolone phenpropionate—Testosterone Propionate—COMT—hypertension	0.000207	0.0454	CrCbGaD
Nandrolone phenpropionate—Nandrolone decanoate—CYP19A1—hypertension	0.000189	0.0414	CrCbGaD
Nandrolone phenpropionate—Progesterone—NR3C2—hypertension	0.00016	0.0349	CrCbGaD
Nandrolone phenpropionate—Testosterone Propionate—AR—hypertension	0.000155	0.0338	CrCbGaD
Nandrolone phenpropionate—Levonorgestrel—AR—hypertension	0.00015	0.0329	CrCbGaD
Nandrolone phenpropionate—Levonorgestrel—CYP19A1—hypertension	0.000126	0.0275	CrCbGaD
Nandrolone phenpropionate—Progesterone—CYP17A1—hypertension	0.000117	0.0256	CrCbGaD
Nandrolone phenpropionate—Norethindrone—CYP3A5—hypertension	0.000111	0.0242	CrCbGaD
Nandrolone phenpropionate—Testosterone—CYP11A1—hypertension	0.000109	0.0238	CrCbGaD
Nandrolone phenpropionate—Progesterone—ABCC1—hypertension	0.000106	0.0232	CrCbGaD
Nandrolone phenpropionate—Progesterone—AR—hypertension	7.1e-05	0.0155	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PRKCA—hypertension	6.89e-05	0.000994	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—hypertension	6.84e-05	0.000986	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTM1—hypertension	6.8e-05	0.000981	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—hypertension	6.77e-05	0.000976	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—AR—hypertension	6.71e-05	0.0147	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTM1—hypertension	6.71e-05	0.000967	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP4A11—hypertension	6.69e-05	0.000965	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CDKN1A—hypertension	6.6e-05	0.000951	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—PTEN—hypertension	6.58e-05	0.000949	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NPPA—hypertension	6.52e-05	0.00094	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP1A1—hypertension	6.45e-05	0.00093	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—CYP3A5—hypertension	6.45e-05	0.0141	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGIS—hypertension	6.44e-05	0.000929	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MMP1—hypertension	6.42e-05	0.000925	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—FAH—hypertension	6.36e-05	0.000918	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP1A1—hypertension	6.36e-05	0.000917	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—EP300—hypertension	6.28e-05	0.000905	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—FGFR1—hypertension	6.22e-05	0.000897	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HSD11B1—hypertension	6.22e-05	0.000897	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ABCC1—hypertension	6.22e-05	0.000897	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—SRC—hypertension	6.1e-05	0.00088	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—CYP3A5—hypertension	6.09e-05	0.0133	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP11B2—hypertension	6.02e-05	0.000869	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ALAS1—hypertension	6.02e-05	0.000869	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—hypertension	5.96e-05	0.000859	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B1—hypertension	5.93e-05	0.000856	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—hypertension	5.9e-05	0.000851	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—FADS1—hypertension	5.85e-05	0.000843	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—TBXAS1—hypertension	5.69e-05	0.00082	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—CYP19A1—hypertension	5.62e-05	0.0123	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5AP—hypertension	5.54e-05	0.000799	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ALOX15—hypertension	5.54e-05	0.000799	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—LHB—hypertension	5.41e-05	0.00078	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HADHA—hypertension	5.41e-05	0.00078	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—EGFR—hypertension	5.35e-05	0.000772	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—hypertension	5.29e-05	0.000763	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—LPA—hypertension	5.29e-05	0.000763	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BCL2—hypertension	5.21e-05	0.000751	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—AKT1—hypertension	5.13e-05	0.00074	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—CTGF—hypertension	5.11e-05	0.000737	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—LRP2—hypertension	5.07e-05	0.000731	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NR3C2—hypertension	5e-05	0.00072	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MTOR—hypertension	4.99e-05	0.00072	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—IGF1—hypertension	4.94e-05	0.000713	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HSPG2—hypertension	4.88e-05	0.000704	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PNMT—hypertension	4.82e-05	0.000695	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—QDPR—hypertension	4.82e-05	0.000695	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HAS1—hypertension	4.82e-05	0.000695	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HAS2—hypertension	4.82e-05	0.000695	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HAS3—hypertension	4.82e-05	0.000695	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HYAL2—hypertension	4.82e-05	0.000695	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—NR3C1—hypertension	4.81e-05	0.0105	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—POMC—hypertension	4.81e-05	0.000693	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5—hypertension	4.71e-05	0.00068	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—ESR2—hypertension	4.68e-05	0.000674	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CXCL8—hypertension	4.67e-05	0.000674	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—FGF2—hypertension	4.54e-05	0.000655	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTA5—hypertension	4.53e-05	0.000654	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL1B—hypertension	4.48e-05	0.000646	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—hypertension	4.48e-05	0.000646	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NOTCH2—hypertension	4.43e-05	0.000639	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—CYP1A1—hypertension	4.37e-05	0.00957	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BCL2—hypertension	4.31e-05	0.000622	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—PTEN—hypertension	4.31e-05	0.000622	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MDH1—hypertension	4.3e-05	0.00062	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HYAL1—hypertension	4.3e-05	0.00062	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTT2—hypertension	4.3e-05	0.00062	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CDO1—hypertension	4.3e-05	0.00062	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CPS1—hypertension	4.3e-05	0.00062	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—hypertension	4.29e-05	0.000619	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—HDAC1—hypertension	4.25e-05	0.000612	CbGpPWpGaD
Nandrolone phenpropionate—Norethindrone—ALB—hypertension	4.18e-05	0.00915	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—hypertension	4.17e-05	0.000602	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NEDD4L—hypertension	4.14e-05	0.000597	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—CYP1A1—hypertension	4.13e-05	0.00905	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—EP300—hypertension	4.11e-05	0.000593	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP4F12—hypertension	4.1e-05	0.000591	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GCH1—hypertension	4.1e-05	0.000591	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—hypertension	4.1e-05	0.000591	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—hypertension	4.09e-05	0.00059	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CETP—hypertension	4.05e-05	0.000584	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—EP300—hypertension	4.01e-05	0.000578	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PLCD1—hypertension	3.93e-05	0.000567	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—VEGFA—hypertension	3.9e-05	0.000562	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—hypertension	3.88e-05	0.00056	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—hypertension	3.84e-05	0.000554	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—VEGFA—hypertension	3.8e-05	0.000547	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—AKT1—hypertension	3.79e-05	0.000547	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP11B1—hypertension	3.78e-05	0.000546	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AHCY—hypertension	3.78e-05	0.000546	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—VDR—hypertension	3.71e-05	0.000535	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—hypertension	3.71e-05	0.000535	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—hypertension	3.7e-05	0.000533	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HMGCR—hypertension	3.67e-05	0.000529	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTM5—hypertension	3.65e-05	0.000527	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GBA—hypertension	3.65e-05	0.000527	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—EPHX2—hypertension	3.65e-05	0.000527	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—DBH—hypertension	3.65e-05	0.000527	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALOX12—hypertension	3.65e-05	0.000527	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—GATA4—hypertension	3.6e-05	0.000519	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MYC—hypertension	3.58e-05	0.000517	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—hypertension	3.58e-05	0.000516	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—hypertension	3.57e-05	0.000515	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP2J2—hypertension	3.54e-05	0.00051	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—EP300—hypertension	3.54e-05	0.00051	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—EGFR—hypertension	3.51e-05	0.000506	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—hypertension	3.5e-05	0.000504	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—DECR1—hypertension	3.44e-05	0.000495	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ARG1—hypertension	3.44e-05	0.000495	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GLS2—hypertension	3.44e-05	0.000495	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—COX5B—hypertension	3.44e-05	0.000495	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EP300—hypertension	3.41e-05	0.000491	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—hypertension	3.35e-05	0.000483	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NR3C1—hypertension	3.34e-05	0.000482	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—SRC—hypertension	3.31e-05	0.000478	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALAD—hypertension	3.26e-05	0.00047	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TNF—hypertension	3.25e-05	0.000469	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—hypertension	3.23e-05	0.000465	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NPPA—hypertension	3.14e-05	0.000452	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PPARA—hypertension	3.13e-05	0.000451	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PLCE1—hypertension	3.11e-05	0.000448	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—STS—hypertension	3.11e-05	0.000448	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALDH7A1—hypertension	3.11e-05	0.000448	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MYC—hypertension	3.08e-05	0.000445	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—hypertension	3.02e-05	0.000435	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP4A11—hypertension	2.98e-05	0.00043	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CBS—hypertension	2.98e-05	0.00043	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ARG2—hypertension	2.98e-05	0.00043	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MYC—hypertension	2.97e-05	0.000428	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—hypertension	2.96e-05	0.000427	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TP53—hypertension	2.94e-05	0.000424	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—XDH—hypertension	2.92e-05	0.000421	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—hypertension	2.9e-05	0.000419	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGIS—hypertension	2.87e-05	0.000414	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC5A2—hypertension	2.87e-05	0.000414	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP3A5—hypertension	2.87e-05	0.000414	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—hypertension	2.82e-05	0.000406	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HSD11B1—hypertension	2.77e-05	0.000399	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—UCP3—hypertension	2.77e-05	0.000399	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TPH1—hypertension	2.77e-05	0.000399	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—UCP2—hypertension	2.77e-05	0.000399	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ABCC1—hypertension	2.77e-05	0.000399	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TNF—hypertension	2.77e-05	0.000399	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NOTCH1—hypertension	2.74e-05	0.000395	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—APOB—hypertension	2.68e-05	0.000387	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP11B2—hypertension	2.68e-05	0.000387	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALAS1—hypertension	2.68e-05	0.000387	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC2A3—hypertension	2.68e-05	0.000387	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HSD3B1—hypertension	2.64e-05	0.000381	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ADA—hypertension	2.64e-05	0.000381	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL6—hypertension	2.62e-05	0.000379	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AQP1—hypertension	2.6e-05	0.000376	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—FADS1—hypertension	2.6e-05	0.000376	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PPARG—hypertension	2.59e-05	0.000373	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—LPL—hypertension	2.56e-05	0.00037	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CA9—hypertension	2.53e-05	0.000365	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TBXAS1—hypertension	2.53e-05	0.000365	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TP53—hypertension	2.53e-05	0.000365	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—hypertension	2.5e-05	0.000361	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—AKT1—hypertension	2.49e-05	0.000358	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—hypertension	2.48e-05	0.000357	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALOX15—hypertension	2.47e-05	0.000356	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALOX5AP—hypertension	2.47e-05	0.000356	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—CTGF—hypertension	2.46e-05	0.000355	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TP53—hypertension	2.44e-05	0.000352	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CD36—hypertension	2.44e-05	0.000351	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—LHB—hypertension	2.41e-05	0.000347	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HADHA—hypertension	2.41e-05	0.000347	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HSD3B2—hypertension	2.35e-05	0.00034	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—KCNJ11—hypertension	2.35e-05	0.00034	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—LPA—hypertension	2.35e-05	0.00034	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—SERPINE1—hypertension	2.33e-05	0.000336	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—ALB—hypertension	2.3e-05	0.00504	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—hypertension	2.26e-05	0.000327	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP2C18—hypertension	2.26e-05	0.000326	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—LRP2—hypertension	2.26e-05	0.000326	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—ESR2—hypertension	2.25e-05	0.000325	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—AGT—hypertension	2.19e-05	0.000316	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HSPG2—hypertension	2.17e-05	0.000313	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—hypertension	2.15e-05	0.00031	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—hypertension	2.14e-05	0.000308	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NOTCH2—hypertension	2.13e-05	0.000308	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—hypertension	2.13e-05	0.000307	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—hypertension	2.12e-05	0.000306	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALOX5—hypertension	2.1e-05	0.000303	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GLP1R—hypertension	2.1e-05	0.000303	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—hypertension	2.06e-05	0.000297	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HDAC1—hypertension	2.04e-05	0.000295	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALDH2—hypertension	1.92e-05	0.000277	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—hypertension	1.87e-05	0.00027	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HBA1—hypertension	1.87e-05	0.00027	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP11A1—hypertension	1.86e-05	0.000268	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—hypertension	1.85e-05	0.000266	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTT1—hypertension	1.83e-05	0.000263	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC9A1—hypertension	1.83e-05	0.000263	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GCLC—hypertension	1.8e-05	0.00026	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CETP—hypertension	1.8e-05	0.00026	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—VDR—hypertension	1.79e-05	0.000258	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP17A1—hypertension	1.73e-05	0.000249	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGS1—hypertension	1.71e-05	0.000247	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ENO1—hypertension	1.71e-05	0.000247	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—H2AFX—hypertension	1.69e-05	0.000244	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—hypertension	1.68e-05	0.000243	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PRKCA—hypertension	1.65e-05	0.000238	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CTGF—hypertension	1.65e-05	0.000238	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—YWHAZ—hypertension	1.63e-05	0.000236	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HMGCR—hypertension	1.63e-05	0.000235	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GOT2—hypertension	1.63e-05	0.000235	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	1.61e-05	0.000232	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NR3C1—hypertension	1.61e-05	0.000232	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ADRA2A—hypertension	1.6e-05	0.00023	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PRKCD—hypertension	1.57e-05	0.000227	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PPARA—hypertension	1.51e-05	0.000217	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TH—hypertension	1.5e-05	0.000216	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CALM2—hypertension	1.49e-05	0.000215	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—MYC—hypertension	1.48e-05	0.000213	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—hypertension	1.47e-05	0.000212	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC2A4—hypertension	1.45e-05	0.00021	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GCG—hypertension	1.45e-05	0.00021	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GOT1—hypertension	1.41e-05	0.000203	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—STK11—hypertension	1.37e-05	0.000197	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NOTCH1—hypertension	1.32e-05	0.00019	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—hypertension	1.28e-05	0.000185	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—COMT—hypertension	1.27e-05	0.000183	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GNB3—hypertension	1.25e-05	0.000181	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPARGC1A—hypertension	1.25e-05	0.000181	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HMOX1—hypertension	1.25e-05	0.00018	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PPARG—hypertension	1.25e-05	0.00018	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CAT—hypertension	1.23e-05	0.000178	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—hypertension	1.22e-05	0.000177	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GNAS—hypertension	1.22e-05	0.000176	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—APOB—hypertension	1.2e-05	0.000172	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTM1—hypertension	1.16e-05	0.000168	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—LPL—hypertension	1.14e-05	0.000165	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SERPINE1—hypertension	1.12e-05	0.000162	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ADCY5—hypertension	1.12e-05	0.000161	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GPX1—hypertension	1.11e-05	0.000161	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP1A1—hypertension	1.1e-05	0.000159	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PRKCA—hypertension	1.1e-05	0.000159	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CD36—hypertension	1.08e-05	0.000156	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MTHFR—hypertension	1.03e-05	0.000148	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPARA—hypertension	1.01e-05	0.000145	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AGT—hypertension	9.77e-06	0.000141	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CALM1—hypertension	9.6e-06	0.000138	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—APOE—hypertension	9.57e-06	0.000138	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CAV1—hypertension	9.48e-06	0.000137	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—APOA1—hypertension	9.46e-06	0.000136	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPARG—hypertension	8.34e-06	0.00012	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—POMC—hypertension	8.22e-06	0.000119	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—INS—hypertension	8.18e-06	0.000118	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALB—hypertension	7.49e-06	0.000108	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3R1—hypertension	7.17e-06	0.000103	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NOS3—hypertension	7.17e-06	0.000103	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MYC—hypertension	7.1e-06	0.000102	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGS2—hypertension	6.56e-06	9.46e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTEN—hypertension	5.72e-06	8.25e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—EP300—hypertension	5.45e-06	7.86e-05	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—AKT1—hypertension	4.93e-06	7.1e-05	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AKT1—hypertension	3.3e-06	4.75e-05	CbGpPWpGaD
